Skip to main content

Table 2 VDR gene polymorphism genotype and allele frequencies in the two study groups

From: Protective association of VDR gene polymorphisms and haplotypes with multiple sclerosis patients in Egyptian population

SNP

MS (n = 50)

Controls (n = 50)

Significance

OR (95% CI)

No.

%

No.

%

FokI

 FF (wt)

36

72.0

25

50.0

χ2 = 6.33*

0.42 (0.26–0.85)

 Ff (ht)

14

28.0

22

44.0

MCp = 0.029*

 ff (mut)

0

0.0

3

6.0

 

 F

86

86.0

72

72.0

χ2 = 5.91*

 f

14

14.0

28

28.0

P = 0.015*

BsmI

 BB (mut)

20

40.0

22

44.0

χ2 = 1.24

1.33 (0.76–2.32)

 Bb (ht)

12

24.0

15

30.0

P = 0.54

 bb (wt)

18

36.0

13

26.0

 

 B

52

52.0

59

59.0

χ2 = 0.99

 b

48

48.0

41

41.0

P = 0.32

ApaI

 AA (mut)

20

40.0

36

72.0

χ2 = 11.103*

2.47 (1.25–4.88)

 Aa (ht)

28

56.0

12

24.0

MCp = 0.002*

 aa (wt)

2

4.0

2

4.0

 

 A

68

68.0

84

84.0

χ2 = 7.02*

 a

32

32.0

16

16.0

P = 0.008*

TaqI

 TT (wt)

24

48.0

18

36.0

χ2 = 4.16

0.55 (0.31–0.98)

 Tt (ht)

20

40.0

18

36.0

P = 0.13

 tt (mut)

6

12.0

14

28.0

 

 T

68

68.0

54

54.0

χ2 = 4.12*

 t

32

32.0

46

46.0

P = 0.04*

Tru9I

 UU (wt)

28

56.0

37

74.0

χ2 = 4.80

1.66 (0.82–3.35)

 Uu (ht)

20

40.0

10

20.0

MCp = 0.11

 uu (mut)

2

4.0

3

6.0

 

 U

76

76.0

84

84.0

χ2 = 2.0

 u

24

24.0

16

16.0

P = 0.16

  1. wt homozygote wild type, ht heterozygote mutated, mut homozygote mutated, SNP single nucleotide polymorphism, MCp Monte Carlo test, χ2 chi-square test, OR odds ratio, CI 95% 95% confidence interval
  2. *Significant at P ≤ 0.05